April 2015
PRESS RELEASE:
Former Teva CEO Jeremy Levin heads US start-up
PRESS RELEASE:
Former Teva CEO Jeremy Levin heads US start-up
PRESS RELEASE:
FFX 2014 Donations
PRESS RELEASE:
FFX New Board Members
Fragile X Mental Retardation Protein Regulates Translation by Binding Directly to the Ribosome
NIH grant could be worth up to $10m to SAGE Therapeutics and its Fragile X Syndrome drug
Chilean Conference planned for March 2011 on "Genes To Cognition" with emphasis on Fragile X
NFXF Funds Two-Year Study of Minocycline. Study to look at benefits for children age four and up
UC Davis researchers receive prestigious stimulus grant for stem-cell research on FXTAS